Zobrazeno 1 - 10
of 33
pro vyhledávání: '"David D Waddell"'
Autor:
David D Waddell, Biji Joseph
Publikováno v:
Journal of Knee Surgery. 29:159-168
We retrospectively examined prospective data on the incidence and time to total knee replacement (TKR) in (1) patients with grade IV osteoarthritis (OA) treated with hylan G-F 20 from 1997 to 2010 (full cohort; 1,863 knees) and (2) a patient subset t
Publikováno v:
Journal of Knee Surgery. 28:213-222
An effusion at the onset of viscosupplementation has been thought to diminish the efficacy and increase adverse event rates. This study compares efficacy of hylan G-F 20 in patients with and without an effusion. Patients with knee osteoarthritis (OA)
Autor:
Douglas L. Minke, David D. Waddell
Publikováno v:
Gaming Law Review and Economics. 14:609-615
Autor:
David D. Waddell, Jack M. Bert
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease. 2:127-132
Viscosupplementation (VIS) is one of several treatment modalities for osteoarthritis of the knee. It is useful in the treatment of osteoarthritis when other methods of conservative care have failed and it may be a safer method of treatment than oral
Autor:
David D Waddell, DeWayne C. Bricker
Publikováno v:
The Journal of Knee Surgery. 19:19-27
This retrospective review evaluates the effectiveness and tolerability of hylan G-F 20 for relief of pain due to knee osteoarthritis in a large orthopedic practice over a 5-year period. Prospectively collected data from patients who initiated intra-a
Publikováno v:
The Journal of Knee Surgery. 18:7-15
This prospective open-label study evaluated the efficacy and tolerability of a second course of hylan G-F 20 for the treatment of osteoarthritic knee pain over a 12-month period in patients who previously experienced a beneficial initial course of th
Autor:
David D Waddell, Andrew A. Marino
Publikováno v:
The Journal of Knee Surgery. 20:181-184
Intra-articular injection of exogenous hyaluronan (viscosupplementation) is an effective treatment for knee pain due to osteoarthritis, but the amount of dilution of the viscosupplement by the synovial fluid, which could affect efficacy, has not been
Autor:
David D Waddell, DeWayne C. Bricker
Publikováno v:
Journal of Managed Care Pharmacy. 13:113-121
Total knee replacement (TKR), a last resort for treating knee pain due to osteoarthritis (OA), is not always medically indicated or preferred by many patients. Hylan G-F 20 is a cross-linked hyaluronan derivative approved for the treatment of pain du
Autor:
David D Waddell
Publikováno v:
Current Medical Research and Opinion. 19:575-580
Hylan G-F 20 (Synvisc, Genzyme Biosurgery, Ridgefield, NJ) is a visco supplement indicated for the treatment of pain due to osteoarthritis (OA) of the knee. Overall, the therapy is well tolerated with a low incidence of local and systemic adverse eve
Autor:
David D. Waddell, Robert R. Russell
Publikováno v:
Gaming Law Review. 6:177-183
ANY TIME CASINO GAMING is approved in a new jurisdiction, the inclination of those in government is to assure that the new regulatory system is “one of the toughest in the country.” Unfortunately, in most new jurisdictions, when casino gaming is